Insider · CIK 0001752537

Kay Mark A

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001752537

Forms 4 and 5

Insider transactions

13 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-11-16	LogicBio Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−785K sh	—	—	0
2022-11-16	LogicBio Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−141K sh	—	—	0
2022-11-16	LogicBio Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.1K sh	—	—	0
2022-11-16	LogicBio Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2022-06-17	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-06-18	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2021-06-11	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2021-01-01	LogicBio Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,199 sh	—	—	2,199
2021-01-01	LogicBio Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,199 sh	—	—	0
2020-06-19	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-19	LogicBio Therapeutics, Inc.Restricted Stock UnitsA Award	Director	AAward	+2,199 sh	—	—	2,199
2019-12-19	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+10.9K sh	—	—	10,869
2018-10-18	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+24.1K sh	—	—	24,102

Recent filings

Accepted (ET)
Nov 174
Kay Mark A0000899243-22-036306
SEC(opens sec.gov)
Jun 214
Kay Mark A0001209191-22-038241
SEC(opens sec.gov)
Jun 214
Kay Mark A0001209191-21-042044
SEC(opens sec.gov)
Jun 144
Kay Mark A0001209191-21-040431
SEC(opens sec.gov)
Jan 44
Kay Mark A0001209191-21-000520
SEC(opens sec.gov)
Jun 234
Kay Mark A0001209191-20-038662
SEC(opens sec.gov)
Dec 234
Kay Mark A0001209191-19-061671
SEC(opens sec.gov)
Oct 224
Kay Mark A0000899243-18-027227
SEC(opens sec.gov)

Companies

LogicBio Therapeutics, Inc.Director

Address

C/O LOGICBIO THERAPEUTICS, INC. 610 MAIN STREET, 3RD FLOOR

CAMBRIDGE, MA, 02139